<Record>
<Term>Potassium Channel Blockers</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Membrane Transport Modulators</ParentTerm>
<ParentTerm>Cardiovascular Agents</ParentTerm>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Therapeutic Uses/Cardiovascular Agents/Potassium Channel Blockers</ClassificationPath>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Molecular Mechanisms of Pharmacological Action/Membrane Transport Modulators/Potassium Channel Blockers</ClassificationPath>
<BroaderTerm>Therapeutic Uses</BroaderTerm>
<BroaderTerm>Pharmacologic Actions</BroaderTerm>
<BroaderTerm>Potassium Channel Blockers</BroaderTerm>
<BroaderTerm>Membrane Transport Modulators</BroaderTerm>
<BroaderTerm>Chemical Actions and Uses</BroaderTerm>
<BroaderTerm>Molecular Mechanisms of Pharmacological Action</BroaderTerm>
<BroaderTerm>Cardiovascular Agents</BroaderTerm>
<Synonym>Potassium Channel Blockers</Synonym>
<Description>A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS.</Description>
<Source>MeSH</Source>
</Record>
